Impladent Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Impladent General Information

Description

Manufacturer of regenerative materials intended for bone grafting and repair. The company offers a range of innovative products including synthetic bioactive grafts that closely resemble human trabecular bone, synthetic resorbable bone grafts and synthetic bioactive resorbable grafts (SBRG) that are physiochemically and crystallographically equivalent to human trabecular bone.

Contact Information

Website
www.osteogen.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 86-90 188th street
  • Jamaica, NY 11423
  • United States
+1 (718)
Primary Industry
Medical Supplies
Other Industries
Distributors/Wholesale
Industrial Supplies and Parts
Therapeutic Devices
Other Devices and Supplies
Parent Company
Solmetex
Vertical(s)
Manufacturing
Corporate Office
  • 86-90 188th street
  • Jamaica, NY 11423
  • United States
+1 (718)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impladent Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impladent‘s full profile, request access.

Request a free trial

Impladent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of regenerative materials intended for bone grafting and repair. The company offers a range of innovative p
Medical Supplies
Jamaica, NY
22 As of 2019

Wolhusen, Switzerland
 

Turku, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Impladent Competitors (6)

One of Impladent’s 6 competitors is Geistlich Pharma, a Corporation company based in Wolhusen, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Geistlich Pharma Corporation Wolhusen, Switzerland
Bonalive Biomaterials Corporation Turku, Finland
Biomatlante Formerly VC-backed Vigneux-de-Bretage, France
Regenity Biosciences Private Equity-Backed Paramus, NJ
CoreBone Venture Capital-Backed Misgav, Israel
To view Impladent’s complete competitors history, request access »

Impladent Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • Pending

  • Expiring in next 12 mo

Impladent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10730228-B2 Microtopographic pattern transfer tool Active 21-Apr-2016
US-20170305063-A1 Microtopographic pattern transfer tool Active 21-Apr-2016
US-10980617-B2 Implantable surgical screw for bone reconstruction Inactive 23-Feb-2015
US-20160242874-A1 Implantable surgical screw for bone reconstruction Active 23-Feb-2015
US-9238047-B1 Fluorapatite nano-crystalline coated non-ceramic hydrophilic hydroxylapatite bone grafting compositions and methods for promoting bone regeneration Active 10-Jan-2013 A61K33/42
To view Impladent’s complete patent history, request access »

Impladent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impladent FAQs

  • When was Impladent founded?

    Impladent was founded in 1985.

  • Where is Impladent headquartered?

    Impladent is headquartered in Jamaica, NY.

  • What is the size of Impladent?

    Impladent has 22 total employees.

  • What industry is Impladent in?

    Impladent’s primary industry is Medical Supplies.

  • Is Impladent a private or public company?

    Impladent is a Private company.

  • What is Impladent’s current revenue?

    The current revenue for Impladent is .

  • Who are Impladent’s competitors?

    Geistlich Pharma, Bonalive Biomaterials, Biomatlante, Regenity Biosciences, and CoreBone are some of the 6 competitors of Impladent.

  • When was Impladent acquired?

    Impladent was acquired on 01-Jun-2023.

  • Who acquired Impladent?

    Impladent was acquired by Solmetex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process